Mesa Laboratories, Inc. (MLAB)
128.66
-1.21
(-0.93%)
USD |
NASDAQ |
Oct 27, 16:00
128.66
0.00 (0.00%)
After-Hours: 16:34
Mesa Laboratories Enterprise Value : 857.38M for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 857.38M |
| October 23, 2026 | 850.61M |
| October 22, 2026 | 853.07M |
| October 21, 2026 | 853.63M |
| October 20, 2026 | 831.03M |
| October 19, 2026 | 820.65M |
| October 16, 2026 | 816.03M |
| October 15, 2026 | 845.46M |
| October 14, 2026 | 836.62M |
| October 13, 2026 | 844.46M |
| October 12, 2026 | 847.31M |
| October 09, 2026 | 844.18M |
| October 08, 2026 | 836.06M |
| October 07, 2026 | 857.89M |
| October 06, 2026 | 892.02M |
| October 05, 2026 | 926.55M |
| October 02, 2026 | 872.38M |
| October 01, 2026 | 854.19M |
| September 30, 2026 | 857.77M |
| September 29, 2026 | 863.59M |
| September 28, 2026 | 874.84M |
| September 25, 2026 | 880.72M |
| September 24, 2026 | 900.08M |
| September 23, 2026 | 874.95M |
| September 22, 2026 | 884.02M |
| Date | Value |
|---|---|
| September 21, 2026 | 868.57M |
| September 18, 2026 | 838.75M |
| September 17, 2026 | 842.11M |
| September 16, 2026 | 831.75M |
| September 15, 2026 | 842.16M |
| September 14, 2026 | 810.43M |
| September 11, 2026 | 807.02M |
| September 10, 2026 | 807.24M |
| September 09, 2026 | 824.03M |
| September 08, 2026 | 823.08M |
| September 04, 2026 | 845.69M |
| September 03, 2026 | 849.88M |
| September 02, 2026 | 861.75M |
| September 01, 2026 | 832.76M |
| August 31, 2026 | 846.19M |
| August 28, 2026 | 853.02M |
| August 27, 2026 | 850.56M |
| August 26, 2026 | 842.16M |
| August 25, 2026 | 843.28M |
| August 24, 2026 | 826.33M |
| August 21, 2026 | 828.79M |
| August 20, 2026 | 797.40M |
| August 19, 2026 | 800.59M |
| August 18, 2026 | 734.67M |
| August 17, 2026 | 732.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 51.81B |
| Bio-Rad Laboratories, Inc. | 9.708B |
| Bruker Corp. | 10.53B |
| Danaher Corp. | 185.98B |
| Harvard Bioscience, Inc. | 75.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.83M |
| Revenue (Quarterly) | 60.14M |
| Total Expenses (Quarterly) | 57.31M |
| EPS Diluted (Quarterly) | 0.4916 |
| Gross Profit Margin (Quarterly) | 57.87% |
| Profit Margin (Quarterly) | 4.71% |
| Earnings Yield | 0.66% |
| Operating Earnings Yield | 3.12% |
| Normalized Earnings Yield | 0.6569 |